by Karolinska Institutet Schematic illustration of how brain imaging resp. cerebrospinal fluid measures the accumulation of amyloid protein. Credit: The research team. The two used methods for detecting amyloid pathology in Alzheimer’s disease do not give unambiguous results, with the risk of incorrect or delayed care interventions. Now, researchers at Karolinska Institutet in Sweden have found genetic explanations for the...